|
CN106892909A
|
|
One kind is according to piperazine azoles impurity compound and preparation method thereof
|
|
CN105622614A
|
|
Ibrutinib amorpphis and preparation method thereof
|
|
CN106699637A
|
|
Single pimavanserin tartrate crystal form and preparation method thereof
|
|
CN106706768A
|
|
Method for measuring Jardiance and related substances of Jardiance through separation
|
|
CN106706769A
|
|
Separation and determination method of empagliflozin and optical isomers thereof
|
|
CN106619636A
|
|
Delafloxacin impurity compounds and preparation methods thereof
|
|
CN106588753A
|
|
Pimavanserin preparation method
|
|
CN106589038A
|
|
Method for preparing 3alpha,7alpha-dyhydroxyl-6alpha-ethyl-5beta-cholanic acid
|
|
CN104961799A
|
|
Kyprolis crystal form A and method for preparing same
|
|
CN106317188A
|
|
Method for preparing amorphous substance of carfilzomib
|
|
CN106256824A
|
|
A kind of preparation method of high-purity De Lasha star meglumine salt
|
|
CN106316887A
|
|
Method for preparing isoptopenyl ketone compound
|
|
CN104820028A
|
|
Method for using liquid chromatography to separate and measure apremilast and enantiomer thereof
|
|
CN104844586A
|
|
Amorphous brexpiprazole and preparation method thereof
|
|
CN104829602A
|
|
Brexpiprazole preparation method
|
|
CN104844585A
|
|
Preparation method of brexpiprazole
|
|
CN104829590A
|
|
Trelagliptin purification method
|
|
CN104678026A
|
|
Method for measuring content of tetrabutylammonium bromide in organic drug
|
|
CN104710498A
|
|
Abiraterone butanoate crystal form and preparation method thereof
|
|
CN104710499A
|
|
Crystal form of Abiraterone propionate and preparation method thereof
|
